Showing results (821-830 of 2,226) with videos related to
Sort By:
Pageof 223
Handbook of Experimental Pharmacology|April 9, 2013
The involvement of sphingolipids in chronic obstructive pulmonary diseasesIrina Petrache, Daniela N PetruscaHandbook of Experimental Pharmacology|April 9, 2013
Viral infections and sphingolipidsJürgen Schneider-Schaulies, Sibylle Schneider-SchauliesHandbook of Experimental Pharmacology|April 9, 2013
Sphingolipids in obesity, type 2 diabetes, and metabolic diseaseS B Russo, J S Ross, L A CowartHandbook of Experimental Pharmacology|April 9, 2013
Neuronal forms of Gaucher diseaseEinat B Vitner, Anthony H FutermanHandbook of Experimental Pharmacology|April 9, 2013
Role of sphingosine 1-phosphate in skeletal muscle cell biologyPaola Bruni, Chiara DonatiHandbook of Experimental Pharmacology|April 23, 2013
The epigenetic language of circadian clocksSaurabh Sahar, Paolo Sassone-CorsiHandbook of Experimental Pharmacology|April 23, 2013
Peripheral circadian oscillators in mammalsSteven A Brown, Abdelhalim AzziHandbook of Experimental Pharmacology|April 23, 2013
Cancer chronotherapeutics: experimental, theoretical, and clinical aspectsE Ortiz-Tudela, A Mteyrek, A Ballesta, et al.Handbook of Experimental Pharmacology|April 23, 2013
Pharmacological modulators of the circadian clock as potential therapeutic drugs: focus on genotoxic/anticancer therapyMarina P Antoch, Roman V KondratovHandbook of Experimental Pharmacology|April 23, 2013
Mammalian circadian clock: the roles of transcriptional repression and delayYoichi Minami, Koji L Ode, Hiroki R UedaPageof 223